HRT Compounding & Bioidentical Hormones 3

Question 1

What is the primary criticism major medical organizations such as ACOG raise about compounded bioidentical HRT?

Accepted Answer

Lack of long-term safety and efficacy data from large randomized controlled trials

Answer

Bioidentical hormones are universally too expensive for patients

Answer

Bioidentical hormones cannot be absorbed transdermally

Answer

There are no FDA-approved bioidentical hormone preparations available

Question 2

A significant limitation of saliva hormone testing commonly used in BHRT practices is that it:

Accepted Answer

Shows high variability and lacks standardization compared to serum testing

Answer

Cannot detect estradiol under any circumstances

Answer

Requires a 24-hour collection period to be accurate

Answer

Is only validated for testosterone measurement

Question 3

DHEA (dehydroepiandrosterone) is sometimes included in compounded HRT regimens primarily because it:

Accepted Answer

Is a precursor hormone convertible to estrogen and testosterone

Answer

Directly blocks cortisol production in the adrenal cortex

Answer

Replaces thyroid hormone function in hypothyroid patients

Answer

Is a potent synthetic androgen approved for female HRT

Question 4

Why is a valid patient-practitioner relationship required under Section 503A for compounded HRT prescriptions?

Accepted Answer

It is a legal requirement for the compounding exemption and ensures medically appropriate use

Answer

It is only required when the hormone dose exceeds published FDA guidelines

Answer

It is optional but recommended by most state pharmacy boards

Answer

It applies only to compounded controlled substances, not hormones

Question 5

What distinguishes a 503B outsourcing facility from a 503A traditional compounding pharmacy?

Accepted Answer

503B facilities are FDA-registered, can produce large batches, and are not required to have individual patient prescriptions

Answer

503B facilities may only compound sterile injectable preparations

Answer

503B facilities are exclusively contracted to hospital systems

Answer

503B facilities are required to obtain PCAB accreditation before operating

Question 6

Which statement best describes the FDA's official position on compounded bioidentical HRT?

Accepted Answer

The FDA has not approved compounded BHRT and warns against claims that it is safer or more natural than approved therapies

Answer

The FDA endorses compounded BHRT as a superior alternative to commercial HRT

Answer

The FDA prohibits all forms of compounded hormone therapy

Answer

The FDA requires compounded BHRT to undergo full clinical trials before any dispensing

Question 7

Pregnenolone is sometimes included in compounded HRT programs primarily because it:

Accepted Answer

Is a master precursor convertible to multiple steroid hormones including progesterone, DHEA, and cortisol

Answer

Is a synthetic corticosteroid used primarily for its anti-inflammatory properties

Answer

Directly replaces estrogen function in post-menopausal women without conversion

Answer

Is an FDA-approved treatment for menopausal hot flashes